{"id":"https://openalex.org/W2887682804","doi":"https://doi.org/10.1158/1538-7445.am2018-5677","title":"Abstract 5677: Establishment and application of a panel of PBMC-humanized mouse tumor models in immune-oncology and targeted cancer immunotherapy","display_name":"Abstract 5677: Establishment and application of a panel of PBMC-humanized mouse tumor models in immune-oncology and targeted cancer immunotherapy","publication_year":2018,"publication_date":"2018-07-01","ids":{"openalex":"https://openalex.org/W2887682804","doi":"https://doi.org/10.1158/1538-7445.am2018-5677","mag":"2887682804"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2018-5677","doi":"https://doi.org/10.1158/1538-7445.am2018-5677","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2018-5677","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5100322315","display_name":"Lan Zhang","orcid":"https://orcid.org/0000-0002-9604-853X","observed_orcids":["https://orcid.org/0000-0002-9604-853X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lan Zhang","raw_affiliation_strings":["1CrownBio, Taicang, Jiangsu Province, China;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1CrownBio, Taicang, Jiangsu Province, China;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014474009","display_name":"Haochen Wu","orcid":"https://orcid.org/0009-0007-2682-5421","observed_orcids":["https://orcid.org/0009-0007-2682-5421"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Haochen Wu","raw_affiliation_strings":["1CrownBio, Taicang, Jiangsu Province, China;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1CrownBio, Taicang, Jiangsu Province, China;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100405410","display_name":"Fei Chen","orcid":"https://orcid.org/0000-0002-6988-492X","observed_orcids":["https://orcid.org/0000-0002-6988-492X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Fei Chen","raw_affiliation_strings":["1CrownBio, Taicang, Jiangsu Province, China;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1CrownBio, Taicang, Jiangsu Province, China;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000800938","display_name":"Lianqi Zhao","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lianqi Zhao","raw_affiliation_strings":["1CrownBio, Taicang, Jiangsu Province, China;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1CrownBio, Taicang, Jiangsu Province, China;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110445747","display_name":"Xiaoyu An","orcid":"https://orcid.org/0009-0004-5975-0727","observed_orcids":["https://orcid.org/0009-0004-5975-0727"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xiaoyu An","raw_affiliation_strings":["1CrownBio, Taicang, Jiangsu Province, China;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1CrownBio, Taicang, Jiangsu Province, China;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074145814","display_name":"Weibin Tan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Weibin Tan","raw_affiliation_strings":["2Taicang Blood Center, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Taicang Blood Center, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112382526","display_name":"Xiaoyan Fu","orcid":"https://orcid.org/0009-0000-8646-9851","observed_orcids":["https://orcid.org/0009-0000-8646-9851","https://orcid.org/0009-0003-8476-9967"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xiaoyan Fu","raw_affiliation_strings":["2Taicang Blood Center, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Taicang Blood Center, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006613618","display_name":"Meng Qiao","orcid":"https://orcid.org/0000-0003-4628-1103","observed_orcids":["https://orcid.org/0000-0003-4628-1103"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Meng Qiao","raw_affiliation_strings":["1CrownBio, Taicang, Jiangsu Province, China;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1CrownBio, Taicang, Jiangsu Province, China;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049291606","display_name":"Qian Shi","orcid":"https://orcid.org/0000-0002-4640-8832","observed_orcids":["https://orcid.org/0000-0002-4640-8832"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Qian Shi","raw_affiliation_strings":["1CrownBio, Taicang, Jiangsu Province, China;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1CrownBio, Taicang, Jiangsu Province, China;","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5009616306","display_name":"Wenqing Yang","orcid":"https://orcid.org/0000-0002-4721-6197","observed_orcids":["https://orcid.org/0000-0002-4721-6197"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Wenqing Yang","raw_affiliation_strings":["1CrownBio, Taicang, Jiangsu Province, China;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1CrownBio, Taicang, Jiangsu Province, China;","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"78","issue":"13_Supplement","first_page":"5677","last_page":"5677"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9735999703407288,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9735999703407288,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.016200000420212746,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.002400000113993883,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/xenograft-models","display_name":"xenograft models","score":0.8360000252723694},{"id":"https://openalex.org/keywords/bispecific-t-cell-engagers","display_name":"bispecific T-cell engagers","score":0.8569999933242798},{"id":"https://openalex.org/keywords/targeted-cancer-immunotherapy","display_name":"targeted cancer immunotherapy","score":0.8989999890327454},{"id":"https://openalex.org/keywords/tumor-antigens","display_name":"tumor antigens","score":0.7630000114440918},{"id":"https://openalex.org/keywords/egfr","display_name":"EGFR","score":0.7480000257492065},{"id":"https://openalex.org/keywords/cd47","display_name":"CD47","score":0.9710000157356262},{"id":"https://openalex.org/keywords/braf","display_name":"BRAF","score":0.9100000262260437},{"id":"https://openalex.org/keywords/pd-l1","display_name":"PD-L1","score":0.9980000257492065},{"id":"https://openalex.org/keywords/graft-versus-host-disease","display_name":"graft-versus-host disease","score":0.8360000252723694}],"concepts":[{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.7004295587539673},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6627329587936401},{"id":"https://openalex.org/C2780674031","wikidata":"https://www.wikidata.org/wiki/Q2012719","display_name":"Cancer immunotherapy","level":4,"score":0.5930986404418945},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5620957612991333},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.5591967105865479},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.5310018062591553},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5140088796615601},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.43657535314559937},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.42306390404701233},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.41949722170829773},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.13985556364059448}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2018-5677","doi":"https://doi.org/10.1158/1538-7445.am2018-5677","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2018-5677","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.98580002784729,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2886757631","https://openalex.org/W2916402283","https://openalex.org/W2407233052","https://openalex.org/W2913572544","https://openalex.org/W2505462110","https://openalex.org/W2122214181","https://openalex.org/W2741719664","https://openalex.org/W1573220582","https://openalex.org/W2990545804","https://openalex.org/W4308394517"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"Monoclonal":[2],"antibodies":[3,25,48],"and":[4,23,29,35,44,65,115,126,141,212,247,270,285,320,351,363],"checkpoint":[5],"blocking":[6],"approaches":[7],"have":[8,37,145,209],"achieved":[9],"remarkable":[10],"success":[11,20],"in":[12,15,51,88,94,132,178,325,361],"cancer":[13,42,100,122,204,365],"immunotherapy":[14,366],"clinical":[16,54],"practices.":[17],"Besides":[18],"the":[19,58,188,199,266,305,371],"of":[21,76,92,107,121,171,225,228,281,353,356,370],"anti-PD-1":[22],"anti-PD-L1":[24],"(such":[26],"as":[27,81],"Keytrude":[28],"Tecentriq),":[30],"two":[31],"bispecific":[32,47,192,310],"antibodies,":[33],"Catumaxomab":[34],"Blinatumomab":[36],"been":[38,210],"approved":[39],"to":[40,186,239,303,316,321],"treat":[41],"patients,":[43],"many":[45],"more":[46],"are":[49,129,299,314],"currently":[50],"pre-clinical":[52],"or":[53,164,219,254],"development.":[55],"To":[56,135,197],"meet":[57],"increasing":[59],"market":[60],"needs":[61],"for":[62,202,374],"fast,":[63],"reliable":[64],"cost":[66],"effective":[67],"mouse":[68,358],"tumor":[69,78,142,150,154,217,229,243,248,271,291,295,359],"model":[70,301,318],"systems,":[71],"we":[72,144],"developed":[73,146],"a":[74,89,105,183,226,354],"panel":[75,355],"humanized":[77],"models,":[79,111,117],"designated":[80],"MiXenoTM":[82,84,200,290],"platform.":[83],"could":[85],"be":[86,262],"used":[87,238],"broad":[90],"spectrum":[91],"applications":[93,324],"immuno-oncology":[95],"drug":[96],"discovery,":[97],"including":[98,112,191,309],"targeted":[99,189,203,364],"immune-therapy.":[101],"Method:":[102],"CrownBio":[103],"has":[104],"collection":[106],"about":[108],"200":[109],"xenograft":[110,207],"subcutaneous,":[113],"orthotropic":[114],"systemic":[116],"which":[118],"covers":[119],"majority":[120],"type.":[123],"Gene":[124],"expression":[125],"mutation":[127],"status":[128],"often":[130],"profiled":[131,211],"these":[133,179],"models.":[134,244],"engage":[136],"both":[137],"host":[138,258],"immune":[139,173,246,267],"system":[140],"antigens,":[143],"some":[147],"specific":[148,157,241,294],"MixenoTM":[149,242],"models":[151,201,208,275,292,360],"by":[152,264,287],"inoculating":[153],"cells":[155,249],"over-expressing":[156],"anti-tumor":[158],"antigens":[159,218,230],"(e.g.":[160,231],"EGFR,":[161,232],"CD47,":[162,233],"Braf":[163],"PD-L1)":[165],"into":[166],"PBMC-humanized":[167,357],"immunocompromised":[168],"mice.":[169],"Reconstitution":[170],"human":[172,176,306],"component":[174],"with":[175,223,293],"PBMCs":[177],"tumor-bearing":[180],"mice":[181],"provides":[182],"useful":[184],"tool":[185],"evaluate":[187,304],"immune-therapeutics":[190],"T":[193],"cell":[194,268,272],"engagers.":[195],"Results:":[196],"validate":[198],"immunotherapy,":[205],"several":[206],"selected":[213],"based":[214],"on":[215],"their":[216,323],"gene":[220],"expression.":[221],"Models":[222],"over-expression":[224],"variety":[227],"Braf,":[234],"PD-L1,":[235],"etc.)":[236],"were":[237,250,276],"develop":[240],"The":[245],"engrafted":[251],"either":[252],"simultaneously":[253],"sequentially.":[255],"Graft":[256],"versus":[257],"disease":[259],"(GvHD)":[260],"can":[261],"managed":[263],"optimizing":[265],"constitution":[269],"engraftment.":[273],"Some":[274],"also":[277],"validated":[278],"using":[279],"stand":[280],"care":[282],"I/O":[283,326],"drugs":[284,308],"characterized":[286],"immune-phenotyping.":[288],"Conclusions:":[289],"antigen":[296],"targeting":[297],"strategy":[298],"valid":[300],"systems":[302],"immuno-modulatory":[307],"antibodies.":[311],"Further":[312],"studies":[313],"needed":[315],"expand":[317],"collections":[319],"extend":[322],"space.":[327],"Citation":[328],"Format:":[329],"Lan":[330],"Zhang,":[331],"Haochen":[332],"Wu,":[333],"Fei":[334],"Chen,":[335],"Lianqi":[336],"Zhao,":[337],"Xiaoyu":[338],"An,":[339],"Weibin":[340],"Tan,":[341],"Xiaoyan":[342],"Fu,":[343],"Meng":[344],"Qiao,":[345],"Qian":[346],"Shi,":[347],"Wenqing":[348],"Yang.":[349],"Establishment":[350],"application":[352],"immune-oncology":[362],"[abstract].":[367],"In:":[368],"Proceedings":[369],"American":[372],"Association":[373],"Cancer":[375,388],"Research":[376],"Annual":[377],"Meeting":[378],"2018;":[379],"2018":[380],"Apr":[381],"14-18;":[382],"Chicago,":[383],"IL.":[384],"Philadelphia":[385],"(PA):":[386],"AACR;":[387],"Res":[389],"2018;78(13":[390],"Suppl):Abstract":[391],"nr":[392],"5677.":[393]},"counts_by_year":[],"updated_date":"2026-10-01T08:54:57.152042","created_date":"2018-08-22T00:00:00"}